These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 30930176

  • 21. [Problems in evaluation of chemicals toxicology safety and opportunity and status quo of research on animal experiment substitute method].
    Hou FX.
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2008 Aug; 26(8):502-5. PubMed ID: 19358771
    [No Abstract] [Full Text] [Related]

  • 22. Alternative methods for developmental toxicity testing.
    Piersma AH.
    Basic Clin Pharmacol Toxicol; 2006 May; 98(5):427-31. PubMed ID: 16635099
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Testing and assessment strategies, including alternative and new approaches.
    Meyer O.
    Toxicol Lett; 2003 Apr 11; 140-141():21-30. PubMed ID: 12676447
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Overview of alternative methodologies in toxicology.
    Gribaldo L.
    Curr Protoc Toxicol; 2007 Nov 11; Chapter 20():Unit20.1. PubMed ID: 20882519
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Developmental toxicity testing in the 21st century: the sword of Damocles shattered by embryonic stem cell assays?
    Seiler A, Oelgeschläger M, Liebsch M, Pirow R, Riebeling C, Tralau T, Luch A.
    Arch Toxicol; 2011 Nov 11; 85(11):1361-72. PubMed ID: 22008952
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Evaluation of the use of human Mesenchymal Stem Cells for acute toxicity tests.
    Scanu M, Mancuso L, Cao G.
    Toxicol In Vitro; 2011 Dec 11; 25(8):1989-95. PubMed ID: 21798340
    [Abstract] [Full Text] [Related]

  • 33. Regulatory toxicology in the twenty-first century: challenges, perspectives and possible solutions.
    Tralau T, Oelgeschläger M, Gürtler R, Heinemeyer G, Herzler M, Höfer T, Itter H, Kuhl T, Lange N, Lorenz N, Müller-Graf C, Pabel U, Pirow R, Ritz V, Schafft H, Schneider H, Schulz T, Schumacher D, Zellmer S, Fleur-Böl G, Greiner M, Lahrssen-Wiederholt M, Lampen A, Luch A, Schönfelder G, Solecki R, Wittkowski R, Hensel A.
    Arch Toxicol; 2015 Jun 11; 89(6):823-50. PubMed ID: 25820917
    [Abstract] [Full Text] [Related]

  • 34. How omics technologies can contribute to the '3R' principles by introducing new strategies in animal testing.
    Kroeger M.
    Trends Biotechnol; 2006 Aug 11; 24(8):343-6. PubMed ID: 16782220
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Flow Cytometry to Evaluate Potential Developmental Toxicants in the Embryonic Stem Cell.
    Lara VM, Santos Roballo KC, Gotardo AT, Ambrósio CE.
    Methods Mol Biol; 2018 Aug 11; 1797():165-175. PubMed ID: 29896691
    [Abstract] [Full Text] [Related]

  • 37. The way forward in reproductive/developmental toxicity testing.
    Spielmann H.
    Altern Lab Anim; 2009 Dec 11; 37(6):641-56. PubMed ID: 20105000
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Use of animals for toxicology testing is necessary to ensure patient safety in pharmaceutical development.
    Mangipudy R, Burkhardt J, Kadambi VJ.
    Regul Toxicol Pharmacol; 2014 Nov 11; 70(2):439-41. PubMed ID: 25058855
    [Abstract] [Full Text] [Related]

  • 40. Pluripotent stem cell derived hepatocyte like cells and their potential in toxicity screening.
    Greenhough S, Medine CN, Hay DC.
    Toxicology; 2010 Dec 30; 278(3):250-5. PubMed ID: 20674645
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.